BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35915791)

  • 1. Analysis of the Diagnostic Efficacy of DOTATATE Imaging Combined with CGA and BSP Detection Mode for NEN Patients with Bone Metastasis.
    Lei L; Du T; Yang J; Cai L; Liu H; Chen Y
    Biomed Res Int; 2022; 2022():6279826. PubMed ID: 35915791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Analysis of the Diagnostic Efficacy of DOTATATE Imaging Combined with CGA and BSP Detection Mode for NEN Patients with Bone Metastasis.
    International BR
    Biomed Res Int; 2023; 2023():9760248. PubMed ID: 38188821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.
    Matar S; Malczewska A; Oberg K; Bodei L; Aslanian H; Lewczuk-Myślicka A; Filosso PL; Suarez AL; Kolasińska-Ćwikła A; Roffinella M; Kos-Kudła B; Ćwikła JB; Drozdov IA; Kidd M; Modlin IM
    Neuroendocrinology; 2020; 110(3-4):185-197. PubMed ID: 30995665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity Dose Reduction in
    Loft M; Carlsen EA; Johnbeck CB; Jensen CV; Andersen FL; Langer SW; Oturai P; Knigge U; Kjaer A
    Mol Imaging Biol; 2022 Aug; 24(4):600-611. PubMed ID: 35167028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Correlation Between [
    Yu J; Li N; Li J; Lu M; Leal JP; Tan H; Su H; Fan Y; Zhang Y; Zhao W; Zhu H; Pomper MG; Zhou Y; Yang Z
    Mol Imaging Biol; 2019 Oct; 21(5):984-990. PubMed ID: 30796708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis.
    Kunikowska J; Pawlak D; Kolasa A; Mikołajczak R; Królicki L
    Clin Nucl Med; 2014 Oct; 39(10):855-61. PubMed ID: 25072928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
    Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
    Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Yu J; Cao F; Zhao X; Xie Q; Lu M; Li J; Yang Z; Sun Y
    Neuroendocrinology; 2022; 112(4):358-369. PubMed ID: 34077939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of Asphericity in Pretherapeutic [
    Wetz C; Apostolova I; Steffen IG; Hofheinz F; Furth C; Kupitz D; Ruf J; Venerito M; Klose S; Amthauer H
    Mol Imaging Biol; 2017 Jun; 19(3):437-445. PubMed ID: 27743210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of gut neuroendocrine tumor disease by multiple synchronous transcript analysis in blood.
    Modlin IM; Drozdov I; Kidd M
    PLoS One; 2013; 8(5):e63364. PubMed ID: 23691035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of CD200 and INSM1 in gastrointestinal and pancreatic neuroendocrine neoplasms and its diagnostic values].
    Cao Z; Cen HB; Wei JG; Qin LZ; Liao W; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1134-1138. PubMed ID: 34619866
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between NEN Bone Metastasis Performance and Tumor Proliferation: 112 Cases of [68Ga]Ga-DOTA-TATE Result Analysis.
    Xie Q; Lu M; Zhai S; Guo R; Du C; Zhu H; Li N; Yu J; Yang Z
    Neuroendocrinology; 2022; 112(7):666-672. PubMed ID: 34649240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum BSP, PSADT, and Spondin-2 levels in prostate cancer and the diagnostic significance of their ROC curves in bone metastasis.
    Zhu BP; Guo ZQ; Lin L; Liu Q
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):61-67. PubMed ID: 28121355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital metastases from neuroendocrine neoplasms: clinical implications and outcomes.
    Kamieniarz L; Armeni E; O'Mahony LF; Leigh C; Miah L; Narayan A; Bhatt A; Cox N; Mandair D; Navalkissoor S; Caplin M; Toumpanakis C
    Endocrine; 2020 Feb; 67(2):485-493. PubMed ID: 31732922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A score derived from routine biochemical parameters increases the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine neoplasms.
    Kruljac I; Vurnek I; Maasberg S; Kust D; Blaslov K; Ladika Davidović B; Štefanović M; Demirović A; Bišćanin A; Filipović-Čugura J; Marić Brozić J; Pape UF; Vrkljan M
    Endocrine; 2018 Jun; 60(3):395-406. PubMed ID: 29633144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Classification System With Prognostic Impact.
    Hayes AR; Furtado O'Mahony L; Quigley AM; Gnanasegaran G; Caplin ME; Navalkissoor S; Toumpanakis C
    Clin Nucl Med; 2022 Jan; 47(1):26-35. PubMed ID: 34874347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Prognostic Value of PET/CT Imaging with Combination of
    Zhang P; Yu J; Li J; Shen L; Li N; Zhu H; Zhai S; Zhang Y; Yang Z; Lu M
    Contrast Media Mol Imaging; 2018; 2018():2340389. PubMed ID: 29681780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of
    Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
    Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of receptor radionuclide therapy with
    Nicolini S; Severi S; Ianniello A; Sansovini M; Ambrosetti A; Bongiovanni A; Scarpi E; Di Mauro F; Rossi A; Matteucci F; Paganelli G
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):923-930. PubMed ID: 29387927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
    Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH
    J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.